Diabetes
| Diabetic kidney
Diabetes
Diabetic kidney
Flash Glucose Monitoring in the Reduction of Hypoglycemia in Diabetic Kidney Disease: A Randomised Controlled Trial
book_2
Source:
ADA 2021 - Poster session
calendar_today
Published on Medfyle:
July 2021
headphones
5
min
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- Flash glucose monitoring (FGM) has been shown to be effective in reducing hypoglycemia in type 1 and 2 diabetes in the absence of chronic kidney disease (CKD).
- In this single-center study in 94 patients with diabetes and CKD, FGM was effective in reducing hypoglycemia and improving HbA1c.
- FGM did not significantly differ from self-monitoring of blood glucose (SMBG) when accompanied by hypoglycemia education.
- FGM was acceptable in this population with high sensor use.
Presenting Author
Read more
arrow_downward
Hide
arrow_upward
Elaine Chow
Hong Kong, China
Disclosure: Research Support; Self; Medtronic, Speaker's Bureau; Self; Novartis Pharmaceuticals Corporation, Sanofi-Aventis.
